Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
21 drugs in development
By Therapeutic Area
top 6
R&D Momentum
91/100
Pipeline Velocity
68/100
Trial Completion Rate
72/100
Pipeline Concentration
12/100
Pipeline Freshness
65/100
Strategic Signals
Activity
Last 14 days
Empowered Relief for Youth: A Feasibility Study of a Pain Management Class for Youth With Pain
Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site
Low-dose Naltrexone for Bladder Pain Syndrome: A Randomized Placebo-controlled Prospective Pilot Trial
Improving Outcomes in Pediatric Diabetes: Building the Evidence Base to Inform Effective Diabetes Technology Interventions
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
Virtually Supervised Exercise for Kidney Transplant Candidates
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)
The Effect of a Bioactive Fabric Sleeve on Recovery in Division I Collegiate Baseball Players
Stanford-Matter Neuroscience High-Resolution fMRI Advanced Neurofeedback Feasibility Trial (fMRI Neurofeedback) Medical
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)